VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Stock Comparison

Alcon Inc. vs ChemoMetec A/S

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Alcon Inc.

ALC · New York Stock Exchange

Market cap (USD)$37B
Gross margin (TTM)54.8%
Operating margin (TTM)13.1%
Net margin (TTM)9.4%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryCH
Data as of2026-01-10
Moat score
71/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Alcon Inc.'s moat claims, evidence, and risks.

View ALC analysis

ChemoMetec A/S

CHEMM · Nasdaq Copenhagen A/S

Market cap (USD)
Gross margin (TTM)
Operating margin (TTM)
Net margin (TTM)
SectorHealthcare
Industry
CountryDK
Data as of2026-04-24
Moat score
67/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into ChemoMetec A/S's moat claims, evidence, and risks.

View CHEMM analysis

Comparison highlights

  • Moat score gap: Alcon Inc. leads (71 / 100 vs 67 / 100 for ChemoMetec A/S).
  • Segment focus: Alcon Inc. has 2 segments (56% in Surgical); ChemoMetec A/S has 2 segments (94.8% in Life science research, cell and gene therapy, and bioprocessing).
  • Moat breadth: Alcon Inc. has 7 moat types across 3 domains; ChemoMetec A/S has 4 across 2.

Primary market context

Alcon Inc.

Surgical

Market

Ophthalmic surgical devices (implantables, consumables, equipment) and related service/training

Geography

Global

Customer

Ophthalmic surgeons, hospitals, ambulatory surgery centers, group purchasing organizations

Role

Medical device OEM with direct service, clinical support, and training

Revenue share

56%

ChemoMetec A/S

Life science research, cell and gene therapy, and bioprocessing

Market

Global cell counting and analysis instruments for LCB workflows

Geography

Global, skewed to USA/Canada and Europe

Customer

Pharmaceutical, biotech, cell and gene therapy, bioprocessing, and research labs

Role

OEM instrument, consumables, software, and service provider

Revenue share

94.8%

Side-by-side metrics

Alcon Inc.
ChemoMetec A/S
Ticker / Exchange
ALC - New York Stock Exchange
CHEMM - Nasdaq Copenhagen A/S
Market cap (USD)
$37B
n/a
Gross margin (TTM)
54.8%
n/a
Operating margin (TTM)
13.1%
n/a
Net margin (TTM)
9.4%
n/a
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
n/a
HQ country
CH
DK
Primary segment
Surgical
Life science research, cell and gene therapy, and bioprocessing
Market structure
Oligopoly
Oligopoly
Market share
40%-46% (implied)
15%-25% (estimated)
HHI estimate
n/a
n/a
Pricing power
Moderate
Moderate
Moat score
71 / 100
67 / 100
Moat domains
Demand, Supply, Legal
Demand, Network
Last update
2026-01-10
2026-04-24

Moat coverage

Shared moat types

Installed Base ConsumablesBrand Trust

Alcon Inc. strengths

Suite BundlingService Field NetworkCompliance AdvantageProcurement InertiaCapex Knowhow Scale

ChemoMetec A/S strengths

Design In QualificationInteroperability Hub

Segment mix

Alcon Inc. segments

Full profile >

Surgical

Oligopoly

56%

Vision Care

Oligopoly

44%

ChemoMetec A/S segments

Full profile >

Life science research, cell and gene therapy, and bioprocessing

Oligopoly

94.8%

Production control and quality control of animal semen, beer and milk

Quasi-Monopoly

5.2%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.